Positive Results Move Anemia Contender Enarodustat Towards First Filing

 
• By Ian Haydock

Japanese firms unveil pivotal top-line results that pave way for first filing of novel anemia therapy within new class of agents, but competition is high and timings remain unclear.

Human kidney on scientific background. 3d illustration
JT/Torii's Enarodustat Moves Towards First Filing • Source: Shutterstock

More from Japan

More from Focus On Asia